Posted by Michael Wonder on 01 Aug 2025
Norgine welcomes PBS listing in Australia of Ifinwil (eflornithine) for patients with high-risk neuroblastoma
1 August 2025 - Approximately 50 children in Australia are diagnosed with neuroblastoma each year, with nearly half classified as having high-risk neuroblastoma.
Norgine announced today the inclusion of Ifinwil (eflornithine) on Australia's PBS.
